ADC Therapeutics
Paul Wong is an accomplished professional in Quality Assurance, currently serving as Senior Director at ADC Therapeutics since January 2017, after previously holding the Director position there. Prior experience includes roles as Associate Director at V2 Bio-Consulting, Inc., Sr. Manager at Bayer Pharmaceuticals, and Manager of Quality Engineering at MedImmune. Notably, Paul led a diverse team to modernize validation programs and collaborated with senior leaders across various disciplines. Paul holds a Bachelor's Degree in Integrative Biology from the University of California, Berkeley, an MBA from the University of Massachusetts Lowell, and an Advanced Certificate in Regulatory Affairs from California State University - East Bay.
This person is not in any teams
This person is not in any offices
ADC Therapeutics
2 followers
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.